Trial record 1 of 1 for:    PTC299 breast
Previous Study | Return to List | Next Study

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
PTC Therapeutics
ClinicalTrials.gov Identifier:
NCT00508586
First received: July 26, 2007
Last updated: April 6, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)